Leading the Way in Life Science Technologies

GEN Exclusives

More »

Insight & Intelligence™

Back to Item »

This Month Last Year: Benlysta and Yervoy Approvals, Amgen’s Vectibix, and Daiichi’s Plexxicon Acquisition

Drug sanctions mark new options for lupus and melanoma, while Amgen and Daiichi saw success with business expansion.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »